Photo = Yonhap News
SK Group subsidiaries showed the highest growth rate among subsidiaries last year. This is because the portfolio was concentrated on rechargeable batteries, batteries, and bio, which was advantageous in the growth stock rally. However, as the market interest rate rises and bad news bursts at once, it is on a plunge. Even among the ants, there is a saying that “it is falling so fast that it does not even give him a chance to escape.”
On the 24th, SK Chemicals ended at 267,000 won, down 2.38%. Compared to this year’s highest point of 462,500 won (February 3rd), it is at the level of half. SK Biopharm’s share price dropped from 16,500 won at the beginning of the year to 106,500 won. SK Innovation, which rose to 317,000 won last month, fell to 204,500 won. SK D&D, which was attracting attention as a renewable energy stock, also fell 25% from the beginning of the year.
SK Holdings, a holding company, also received a direct hit. The stock price, which was 350,000 won at the end of January, dropped to 244,000 won. SK Bioscience, which was recently listed, ended at 136,500 won on the same day. It fell close to 30% compared to the intraday peak (190,000 won). SK Hynix, which supported the share prices of subsidiaries, is also on a downtrend. In addition, stock prices of SK Materials, SK Telecom, and SK Discovery are also stagnating.
The reason for the decline in SK Group stocks is the result of overlapping market conditions and individual bad news. SK Chemicals’ AstraZeneca Corona 19 vaccine stability issue, which had a contract for consignment production (CMO), adversely affected the stock price. SK Innovation was hit by Volkswagen’s declaration of battery independence. SK Innovation is known to have the highest order balance for Volkswagen among the three battery companies.
The rise in interest rates has also deteriorated investment sentiment for growth stocks. Rechargeable batteries, bio, and hydrogen, which SK Group is focusing on, are representative industries belonging to growth stocks. There is also an analysis that the decline is greater as the stock price surged last year. It is said that it is getting more hit this year as profit-taking has been achieved around the stocks that have gone up. In the case of SK Chemicals, last year’s increase rate exceeded 500%.
It was the ants that bought these SK Group stocks. This is the reason why people say that the fall is excessive. Individual investors have bought SK Innovation for a net worth of KRW 1.2 trillion since the beginning of the year. During the same period, SK Biopharm purchased KRW 1.55 trillion, SK Corp., KRW 2347 billion, and SK Chemicals KRW 122.4 billion. In addition, SK Hynix (1.346 trillion won) and SK Bioscience (228.6 billion won) were also bought.
SK Chemicals’ sales of the Corona 19 vaccine will be reflected from the first quarter. This year’s overall operating profit is expected to increase by 294% compared to last year to 462 billion won. The target price is KRW550,000, which is twice as high as the current share price. SK D&D’s operating profit is expected to increase by 10.3% this year to 111.2 billion won. However, it is expected that its value as a new and renewable company could stand out.
Reporter Park Uimyung [email protected]
Ⓒ Hankyung.com prohibits unauthorized reproduction and redistribution